07:01 AM EST, 11/05/2025 (MT Newswires) -- Elanco Animal Health ( ELAN ) reported Q3 adjusted earnings Wednesday of $0.19 per share, up from $0.13 a year earlier.

Analysts polled by FactSet expected $0.13.

Revenue for the quarter ended Sept. 30 was $1.14 billion, compared with $1.03 billion a year earlier. The consensus among analysts was for $1.09 billion.

The company said it expects Q4 adjusted EPS of $0.09 to $0.12 with revenue of $1.09 billion to $1.11 billion. Analysts are expecting adjusted EPS of $0.13 and revenue of $1.08 billion.

Elanco raised its 2025 guidance and said it now expects $0.91 to $0.94 in adjusted EPS, from $0.85 to $0.91 previously. Analysts polled by FactSet expect $0.90. Revenue for the year is now estimated at $4.65 billion to $4.67 billion, from the previous range of $4.57 billion to $4.62 billion. Analysts expect $4.60 billion.

Shares of Elanco Animal Health ( ELAN ) were up more than 4% in recent premarket activity Wednesday.